Human Genome Sciences Institutional Investors Increase Shares in HGSI

Date: 2/16/2011

Human Genome Sciences Institutional Investors Increase Shares in HGSI. Institutional Investors Update for HGSI Human Genome Sciences Inc. GENZ Genyzme 2nd Largest Biotech Buyout in History. Sanofi Buys Genzyme for Over $20 Billion. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Leerink Swann Conference. "Top biotech stock" to be HGSI or a possible "HGSI takeover" as institutional investors and traders continue to add to their current position. "Biotech sector" update on HGSI .

Genzyme (GENZ) disappointed on both its bottom and top line, but the company has agreed to be purchased by Sanofi-Aventis (SNY) for $74 per share plus a Contingent Value Right. Institutional Investors Increase Shares in HGSI. Learn more about biotech stock trading

Link to this page http://www.stockmarketfunding.com, notify us and we will consider your web site to our directory

StockMarketFunding.com, LLC is not a registered broker-dealer, but rather works in coordination with fully licensed broker-dealers, SIPC-insured clearing firms, and private trading firms to provide licensed and non-licensed clients with access to career trading programs and direct access trading capabilities. Our firm and our network affiliates strongly recommend that all clients fully read and acknowledge all SEC risk disclosure statements available on our site and our affiliate broker-dealer websites prior to engaging in any live trading activity, and acquire a solid understanding of the risks inherent in all types of stock and option trading.